{"id":"https://openalex.org/W4396639677","doi":"https://doi.org/10.1016/j.ahj.2024.05.002","title":"Obicetrapib on top of maximally tolerated lipid\u2010modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN","display_name":"Obicetrapib on top of maximally tolerated lipid\u2010modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN","publication_year":2024,"publication_date":"2024-05-04","ids":{"openalex":"https://openalex.org/W4396639677","doi":"https://doi.org/10.1016/j.ahj.2024.05.002","pmid":"https://pubmed.ncbi.nlm.nih.gov/38705341"},"language":"en","primary_location":{"id":"doi:10.1016/j.ahj.2024.05.002","doi":"https://doi.org/10.1016/j.ahj.2024.05.002","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ahj.2024.05.002","pdf_url":null,"source":{"id":"https://openalex.org/S46995015","display_name":"American Heart Journal","issn_l":"0002-8703","issn":["0002-8703","1097-6744"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Heart Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.ahj.2024.05.002","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055849986","display_name":"Stephen James Nicholls","orcid":"https://orcid.org/0000-0002-9668-4368","observed_orcids":["https://orcid.org/0000-0002-9668-4368"]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Stephen J. Nicholls","raw_affiliation_strings":["Victorian Heart Institute, Monash University, Victoria, Australia. Electronic address: stephen.nicholls@monash.edu","Victorian Heart Institute, Monash University, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Victorian Heart Institute, Monash University, Victoria, Australia. Electronic address: stephen.nicholls@monash.edu","institution_ids":["https://openalex.org/I56590836"]},{"raw_affiliation_string":"Victorian Heart Institute, Monash University, Victoria, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059089207","display_name":"Adam J. Nelson","orcid":"https://orcid.org/0000-0003-0990-2548","observed_orcids":["https://orcid.org/0000-0003-0990-2548"]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Adam J. Nelson","raw_affiliation_strings":["Victorian Heart Institute, Monash University, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Victorian Heart Institute, Monash University, Victoria, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079365240","display_name":"Marc Ditmarsch","orcid":"https://orcid.org/0000-0002-2970-1893","observed_orcids":["https://orcid.org/0000-0002-2970-1893"]},"institutions":[{"id":"https://openalex.org/I4405272097","display_name":"NewAmsterdam Pharma (Netherlands)","ror":"https://ror.org/03jdnwh76","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405272097"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marc Ditmarsch","raw_affiliation_strings":["NewAmsterdam Pharma, Naarden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewAmsterdam Pharma, Naarden, The Netherlands","institution_ids":["https://openalex.org/I4405272097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077848934","display_name":"John J.P. Kastelein","orcid":"https://orcid.org/0000-0003-2018-4532","observed_orcids":["https://orcid.org/0000-0003-2018-4532"]},"institutions":[{"id":"https://openalex.org/I4405272097","display_name":"NewAmsterdam Pharma (Netherlands)","ror":"https://ror.org/03jdnwh76","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405272097"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"John J.P. Kastelein","raw_affiliation_strings":["NewAmsterdam Pharma, Naarden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewAmsterdam Pharma, Naarden, The Netherlands","institution_ids":["https://openalex.org/I4405272097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052604218","display_name":"Christie Mitchell Ballantyne","orcid":"https://orcid.org/0000-0002-6432-1730","observed_orcids":["https://orcid.org/0000-0002-6432-1730"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christie M. Ballantyne","raw_affiliation_strings":["Baylor College of Medicine and the Texas Heart Institute, Houston, TX","Baylor College of Medicine and the Texas Heart Institute, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine and the Texas Heart Institute, Houston, TX","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Baylor College of Medicine and the Texas Heart Institute, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006206326","display_name":"Kausik Kumar Ray","orcid":"https://orcid.org/0000-0003-0508-0954","observed_orcids":["https://orcid.org/0000-0003-0508-0954","https://orcid.org/0000-0002-7166-060X"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kausik K. Ray","raw_affiliation_strings":["Department of Primary Care and Public Health, Imperial College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Primary Care and Public Health, Imperial College London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048673551","display_name":"Ann Marie N\u00e1var","orcid":"https://orcid.org/0000-0002-6197-9860","observed_orcids":["https://orcid.org/0000-0002-6197-9860"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann Marie Navar","raw_affiliation_strings":["University of Texas Southwestern Medical Center, Dallas, TX","University of Texas Southwestern Medical Center, Dallas, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]},{"raw_affiliation_string":"University of Texas Southwestern Medical Center, Dallas, TX, USA","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040589473","display_name":"Steven E. Nissen","orcid":"https://orcid.org/0000-0002-7231-6464","observed_orcids":["https://orcid.org/0000-0002-7231-6464"]},"institutions":[{"id":"https://openalex.org/I36373038","display_name":"Cleveland Clinic Lerner College of Medicine","ror":"https://ror.org/02x4b0932","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750","https://openalex.org/I36373038"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven E. Nissen","raw_affiliation_strings":["Cleveland Clinic Lerner School of Medicine at Case Western Reserve University, Cleveland, OH","Cleveland Clinic Lerner School of Medicine at Case Western Reserve University, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Lerner School of Medicine at Case Western Reserve University, Cleveland, OH","institution_ids":["https://openalex.org/I36373038","https://openalex.org/I58956616"]},{"raw_affiliation_string":"Cleveland Clinic Lerner School of Medicine at Case Western Reserve University, Cleveland, OH, USA","institution_ids":["https://openalex.org/I36373038","https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051454169","display_name":"Anne Carol Goldberg","orcid":"https://orcid.org/0000-0002-8876-099X","observed_orcids":["https://orcid.org/0000-0002-8876-099X"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne C. Goldberg","raw_affiliation_strings":["Washington University School of Medicine, St. Louis, MO","Washington University School of Medicine, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]},{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067391389","display_name":"Liam R. Brunham","orcid":"https://orcid.org/0000-0002-3686-3807","observed_orcids":["https://orcid.org/0000-0002-3686-3807"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I4405268566","display_name":"Centre for Heart Lung Innovation","ror":"https://ror.org/01bc33a41","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1301114164","https://openalex.org/I141945490","https://openalex.org/I4405268566"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Liam R. Brunham","raw_affiliation_strings":["UBC Centre for Heart Lung Innovation, The University of British Columbia, Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UBC Centre for Heart Lung Innovation, The University of British Columbia, Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I141945490","https://openalex.org/I4405268566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068123939","display_name":"Danielle L. Curcio","orcid":"https://orcid.org/0009-0005-1672-0760","observed_orcids":["https://orcid.org/0009-0005-1672-0760"]},"institutions":[{"id":"https://openalex.org/I4405272097","display_name":"NewAmsterdam Pharma (Netherlands)","ror":"https://ror.org/03jdnwh76","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405272097"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Danielle Curcio","raw_affiliation_strings":["NewAmsterdam Pharma, Naarden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewAmsterdam Pharma, Naarden, The Netherlands","institution_ids":["https://openalex.org/I4405272097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093533626","display_name":"Erin Wuerdeman","orcid":"https://orcid.org/0009-0004-2896-2452","observed_orcids":["https://orcid.org/0009-0004-2896-2452"]},"institutions":[{"id":"https://openalex.org/I4405272097","display_name":"NewAmsterdam Pharma (Netherlands)","ror":"https://ror.org/03jdnwh76","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405272097"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Erin Wuerdeman","raw_affiliation_strings":["NewAmsterdam Pharma, Naarden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewAmsterdam Pharma, Naarden, The Netherlands","institution_ids":["https://openalex.org/I4405272097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006314073","display_name":"Annie L Neild","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405272097","display_name":"NewAmsterdam Pharma (Netherlands)","ror":"https://ror.org/03jdnwh76","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405272097"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Annie Neild","raw_affiliation_strings":["NewAmsterdam Pharma, Naarden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewAmsterdam Pharma, Naarden, The Netherlands","institution_ids":["https://openalex.org/I4405272097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015384592","display_name":"Douglas F. Kling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405272097","display_name":"NewAmsterdam Pharma (Netherlands)","ror":"https://ror.org/03jdnwh76","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405272097"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Douglas Kling","raw_affiliation_strings":["NewAmsterdam Pharma, Naarden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewAmsterdam Pharma, Naarden, The Netherlands","institution_ids":["https://openalex.org/I4405272097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101407871","display_name":"Andrew Hsieh","orcid":"https://orcid.org/0000-0001-6671-6878","observed_orcids":["https://orcid.org/0000-0001-6671-6878","https://orcid.org/0009-0004-2371-6869"]},"institutions":[{"id":"https://openalex.org/I4405272097","display_name":"NewAmsterdam Pharma (Netherlands)","ror":"https://ror.org/03jdnwh76","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405272097"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Andrew Hsieh","raw_affiliation_strings":["NewAmsterdam Pharma, Naarden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewAmsterdam Pharma, Naarden, The Netherlands","institution_ids":["https://openalex.org/I4405272097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053831963","display_name":"Mary R. Dicklin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary R. Dicklin","raw_affiliation_strings":["Midwest Biomedical Research, Addison, IL","Midwest Biomedical Research, Addison, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Midwest Biomedical Research, Addison, IL","institution_ids":[]},{"raw_affiliation_string":"Midwest Biomedical Research, Addison, IL, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105286197","display_name":"Brian A. Ference","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Brian A. Ference","raw_affiliation_strings":["Centre for Naturally Randomized Trials, University of Cambridge, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Naturally Randomized Trials, University of Cambridge, Cambridge, UK","institution_ids":["https://openalex.org/I241749"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060503236","display_name":"Ulrich Laufs","orcid":"https://orcid.org/0000-0003-2620-9323","observed_orcids":["https://orcid.org/0000-0003-2620-9323"]},"institutions":[{"id":"https://openalex.org/I4210125843","display_name":"University Hospital Leipzig","ror":"https://ror.org/028hv5492","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210125843"]},{"id":"https://openalex.org/I926574661","display_name":"Leipzig University","ror":"https://ror.org/03s7gtk40","country_code":"DE","type":"education","lineage":["https://openalex.org/I926574661"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ulrich Laufs","raw_affiliation_strings":["Klinik und Poliklinkk f\u00fcr Kardiologie, Leipzig University, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinik und Poliklinkk f\u00fcr Kardiologie, Leipzig University, Germany","institution_ids":["https://openalex.org/I4210125843","https://openalex.org/I926574661"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046431472","display_name":"Maciej Banach","orcid":"https://orcid.org/0000-0001-6690-6874","observed_orcids":["https://orcid.org/0000-0001-6690-6874"]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Maciej Banach","raw_affiliation_strings":["Department of Preventive Cardiology and Lipidologym, Medical University of Lodz (MUL), Lodz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Preventive Cardiology and Lipidologym, Medical University of Lodz (MUL), Lodz, Poland","institution_ids":["https://openalex.org/I4210122071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016139987","display_name":"Roxana Mehran","orcid":"https://orcid.org/0000-0002-5546-262X","observed_orcids":["https://orcid.org/0000-0002-5546-262X"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roxana Mehran","raw_affiliation_strings":["The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY","The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I98704320"]},{"raw_affiliation_string":"The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091523473","display_name":"Alberico Luigi Catapano","orcid":"https://orcid.org/0000-0002-7593-2094","observed_orcids":["https://orcid.org/0000-0002-7593-2094"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4210094922","display_name":"MultiMedica","ror":"https://ror.org/01h8ey223","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094922","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alberico L. Catapano","raw_affiliation_strings":["IRCCS MultiMedica, Milan, Italy; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS MultiMedica, Milan, Italy; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I4210094922"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101777206","display_name":"Michael H. Davidson","orcid":"https://orcid.org/0000-0001-9342-1274","observed_orcids":["https://orcid.org/0000-0001-9342-1274"]},"institutions":[{"id":"https://openalex.org/I4405272097","display_name":"NewAmsterdam Pharma (Netherlands)","ror":"https://ror.org/03jdnwh76","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405272097"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Michael H. Davidson","raw_affiliation_strings":["NewAmsterdam Pharma, Naarden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewAmsterdam Pharma, Naarden, The Netherlands","institution_ids":["https://openalex.org/I4405272097"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":17,"corresponding_author_ids":["https://openalex.org/A5055849986"],"corresponding_institution_ids":["https://openalex.org/I56590836"],"apc_list":{"value":3950,"currency":"USD","value_usd":3950},"apc_paid":{"value":3950,"currency":"USD","value_usd":3950},"fwci":12.6005,"has_fulltext":true,"cited_by_count":47,"citation_normalized_percentile":{"value":0.99183308,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"274","issue":null,"first_page":"32","last_page":"45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obicetrapib","display_name":"obicetrapib","score":1.0},{"id":"https://openalex.org/keywords/cholesteryl-ester-transfer-protein-inhibitors","display_name":"cholesteryl ester transfer protein inhibitors","score":0.9309999942779541},{"id":"https://openalex.org/keywords/atherosclerotic-cardiovascular-disease","display_name":"atherosclerotic cardiovascular disease","score":0.9490000009536743},{"id":"https://openalex.org/keywords/heterozygous-familial-hypercholesterolemia","display_name":"heterozygous familial hypercholesterolemia","score":0.9760000109672546},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.8330000042915344},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.8259999752044678},{"id":"https://openalex.org/keywords/lipoprotein-a","display_name":"lipoprotein(a)","score":0.996999979019165},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.8700000047683716},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.7020000219345093},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8610000014305115},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.8679999709129333},{"id":"https://openalex.org/keywords/glucose-homeostasis","display_name":"glucose homeostasis","score":0.8859999775886536},{"id":"https://openalex.org/keywords/ambulatory-blood-pressure","display_name":"ambulatory blood pressure","score":0.8690000176429749}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9099271297454834},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8729519844055176},{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.822178840637207},{"id":"https://openalex.org/C45505151","wikidata":"https://www.wikidata.org/wiki/Q424706","display_name":"Cholesterylester transfer protein","level":4,"score":0.5691287517547607},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5539504289627075},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5477979183197021},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5435429215431213},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5395784378051758},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.537548303604126},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4815945327281952},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.46366599202156067},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.42376166582107544},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.4181345999240875},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.38271287083625793},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37980738282203674},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3679119050502777},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.10654079914093018},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08294105529785156},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017270","descriptor_name":"Lipoprotein(a)","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D053480","descriptor_name":"Cholesterol Ester Transfer Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1016/j.ahj.2024.05.002","doi":"https://doi.org/10.1016/j.ahj.2024.05.002","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ahj.2024.05.002","pdf_url":null,"source":{"id":"https://openalex.org/S46995015","display_name":"American Heart Journal","issn_l":"0002-8703","issn":["0002-8703","1097-6744"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Heart Journal","raw_type":"journal-article"},{"id":"pmid:38705341","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38705341","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American heart journal","raw_type":"Journal Article"},{"id":"pmh:oai:digitalcommons.library.tmc.edu:baylor_docs-7532","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.library.tmc.edu/baylor_docs/6657","pdf_url":"https://digitalcommons.library.tmc.edu/context/baylor_docs/article/7532/viewcontent/1_s2.0_S0002870324001169_main_compressed.pdf","source":{"id":"https://openalex.org/S4377196655","display_name":"Digital Commons-TMC (Texas Medical Center)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1337852284","host_organization_name":"Texas Medical Center","host_organization_lineage":["https://openalex.org/I1337852284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Faculty, Staff and Students Publications","raw_type":"text"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/e56d2182-d59a-43fc-99fc-704e4e3b3bde","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/files/150632796/Obicetrapib-on-top-of-maximally-tolerated-lipid-modifying-therapies-in-participants-with-or-at-high-risk-for-atheroscler.pdf","pdf_url":"https://pure.amsterdamumc.nl/ws/files/150632796/Obicetrapib-on-top-of-maximally-tolerated-lipid-modifying-therapies-in-participants-with-or-at-high-risk-for-atheroscler.pdf","source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:digitalcommons.wustl.edu:oa_4-7234","doi":null,"is_oa":false,"landing_page_url":"https://digitalcommons.wustl.edu/oa_4/6248","pdf_url":null,"source":{"id":"https://openalex.org/S4306400764","display_name":"Digital Commons@Becker (Washington University School of Medicine)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I204465549","host_organization_name":"Washington University in St. Louis","host_organization_lineage":["https://openalex.org/I204465549"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"2020-Current year OA Pubs","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1016/j.ahj.2024.05.002","doi":"https://doi.org/10.1016/j.ahj.2024.05.002","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ahj.2024.05.002","pdf_url":null,"source":{"id":"https://openalex.org/S46995015","display_name":"American Heart Journal","issn_l":"0002-8703","issn":["0002-8703","1097-6744"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Heart Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4396639677.pdf","grobid_xml":"https://content.openalex.org/works/W4396639677.grobid-xml"},"referenced_works_count":64,"referenced_works":["https://openalex.org/W1488193441","https://openalex.org/W1574102128","https://openalex.org/W1844854928","https://openalex.org/W1969260244","https://openalex.org/W2010353571","https://openalex.org/W2010505181","https://openalex.org/W2048760408","https://openalex.org/W2093260782","https://openalex.org/W2100595390","https://openalex.org/W2115169717","https://openalex.org/W2122049307","https://openalex.org/W2164089346","https://openalex.org/W2605234342","https://openalex.org/W2609543937","https://openalex.org/W2736338239","https://openalex.org/W2749237115","https://openalex.org/W2758144931","https://openalex.org/W2759629908","https://openalex.org/W2762777606","https://openalex.org/W2763860064","https://openalex.org/W2768114183","https://openalex.org/W2793658995","https://openalex.org/W2801341172","https://openalex.org/W2887629426","https://openalex.org/W2971065017","https://openalex.org/W3006116566","https://openalex.org/W3038421643","https://openalex.org/W3040223903","https://openalex.org/W3118385288","https://openalex.org/W3120916025","https://openalex.org/W3129818723","https://openalex.org/W3170272938","https://openalex.org/W3183857127","https://openalex.org/W3193295997","https://openalex.org/W3197233987","https://openalex.org/W3213895219","https://openalex.org/W3216396211","https://openalex.org/W4200546053","https://openalex.org/W4206276470","https://openalex.org/W4206654024","https://openalex.org/W4211109054","https://openalex.org/W4214933886","https://openalex.org/W4220864502","https://openalex.org/W4224124776","https://openalex.org/W4283205448","https://openalex.org/W4292242012","https://openalex.org/W4293253252","https://openalex.org/W4293778394","https://openalex.org/W4310117874","https://openalex.org/W4327676502","https://openalex.org/W4353094075","https://openalex.org/W4362640332","https://openalex.org/W4379259785","https://openalex.org/W4379928014","https://openalex.org/W4382059183","https://openalex.org/W4384277505","https://openalex.org/W4385477314","https://openalex.org/W4387967163","https://openalex.org/W4389193757","https://openalex.org/W4389574595","https://openalex.org/W4390105715","https://openalex.org/W4393647064","https://openalex.org/W6851796101","https://openalex.org/W6853183308"],"related_works":["https://openalex.org/W4410849677","https://openalex.org/W4390105715","https://openalex.org/W7131820938","https://openalex.org/W4292242012","https://openalex.org/W7164805239","https://openalex.org/W4410166033","https://openalex.org/W4415792609","https://openalex.org/W4410850423","https://openalex.org/W7116953858","https://openalex.org/W4413269332"],"abstract_inverted_index":{"BACKGROUND:":[0],"Obicetrapib,":[1],"a":[2,81,130],"novel,":[3],"selective":[4],"cholesteryl":[5],"ester":[6],"transfer":[7],"protein":[8],"(CETP)":[9],"inhibitor,":[10],"reduces":[11],"low-density":[12],"lipoprotein":[13,27],"cholesterol":[14,28],"(LDL-C),":[15],"LDL":[16],"particles,":[17],"apolipoprotein":[18],"(Apo)":[19],"B,":[20,164],"and":[21,24,95,112,122,170,179,196,212,250],"lipoprotein(a)":[22],"[Lp(a)]":[23],"increases":[25],"high-density":[26],"(HDL-C)":[29],"when":[30],"added":[31],"to":[32,46,107,119,155,174,216,253],"statins":[33],"with":[34,52,69,129,227,262,266],"or":[35,57,221,264,277],"without":[36],"ezetimibe.":[37],"By":[38],"substantially":[39],"reducing":[40],"LDL-C,":[41],"obicetrapib":[42,115,218,259],"has":[43],"the":[44,109,148,233,255],"potential":[45,256],"lower":[47],"atherogenic":[48],"lipoproteins":[49],"in":[50,80,127,151,162,172,210,214,242],"patients":[51,261],"atherosclerotic":[53],"cardiovascular":[54,88,190],"disease":[55],"(ASCVD)":[56],"heterozygous":[58],"familial":[59],"hypercholesterolemia":[60],"(HeFH)":[61],"whose":[62,137],"LDL-C":[63,138,152,268],"levels":[64],"remain":[65],"high":[66,85],"despite":[67],"treatment":[68],"available":[70],"maximally":[71,123],"tolerated":[72,124],"lipid-modifying":[73,125],"therapies,":[74],"addressing":[75],"an":[76,117,184,197],"unmet":[77],"medical":[78],"need":[79],"patient":[82],"population":[83],"at":[84],"risk":[86],"for":[87,224,269],"events.":[89],"METHODS":[90],"AND":[91],"RESULTS:":[92],"BROADWAY":[93,181,211],"(NCT05142722)":[94],"BROOKLYN":[96,215],"(NCT05425745)":[97],"are":[98,240,273],"ongoing":[99],"placebo-controlled,":[100],"double-blind,":[101],"randomized":[102,209],"Phase":[103],"III":[104],"trials":[105,239,246],"designed":[106],"examine":[108],"efficacy,":[110],"safety,":[111,177],"tolerability":[113],"of":[114,132,187,193,205,258],"as":[116],"adjunct":[118],"dietary":[120],"intervention":[121],"therapies":[126,272],"participants":[128,207],"history":[131],"ASCVD":[133,263],"and/or":[134],"underlying":[135],"HeFH":[136,265],"is":[139],"not":[140,274],"adequately":[141],"controlled.":[142],"The":[143],"primary":[144],"efficacy":[145,251],"endpoint":[146],"was":[147],"percent":[149],"change":[150],"from":[153,237],"baseline":[154],"day":[156],"84.":[157],"Other":[158],"endpoints":[159],"included":[160,183],"changes":[161],"Apo":[163,167],"non-HDL-C,":[165],"HDL-C,":[166],"A1,":[168],"Lp(a),":[169],"triglycerides":[171],"addition":[173],"parameters":[175],"evaluating":[176],"tolerability,":[178],"pharmacokinetics.":[180],"also":[182],"adjudicated":[185],"assessment":[186],"major":[188],"adverse":[189],"events,":[191],"measurements":[192],"glucose":[194],"homeostasis,":[195],"ambulatory":[198],"blood":[199],"pressure":[200],"monitoring":[201],"substudy.":[202],"A":[203],"total":[204],"2,532":[206],"were":[208],"354":[213],"receive":[217],"10":[219],"mg":[220],"placebo":[222],"(2:1)":[223],"365":[225],"days":[226,231],"follow-up":[228],"through":[229],"35":[230],"after":[232],"last":[234],"dose.":[235],"Results":[236],"both":[238],"anticipated":[241],"2024.":[243],"CONCLUSION:":[244],"These":[245],"will":[247],"provide":[248],"safety":[249],"data":[252],"support":[254],"use":[257],"among":[260],"elevated":[267],"whom":[270],"existing":[271],"sufficiently":[275],"effective":[276],"well-tolerated.":[278]},"counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":24},{"year":2024,"cited_by_count":12}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-05-05T00:00:00"}